Pay in 4 interest-free payments of $6.27 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Reduces glucagon secretion: glucagon is another hormone produced by the pancreas that has the opposite effect of insulin, increasing blood sugar levels, for instance, when the body is fasting
Addressing Current Gaps and Unmet Needs GLP-1R agonists have rapidly evolved from glucose-lowering agents for T2DM to multifaceted therapeutics with FDA- and EMA-approved indications for obesity, cardiovascular disease, chronic kidney disease, diabetic nephropathy, and sleep apnea
Trustpilot rating: 4.0 out of 5.0 stars based on 33,314 user reviews (as of January 13, 2026)
States must cover this indication
US$ 26.60
US$ 26.01
US$ 28.88
